Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
10 Sep 2024
Historique:
received: 04 12 2023
revised: 02 05 2024
accepted: 16 05 2024
medline: 5 9 2024
pubmed: 5 9 2024
entrez: 4 9 2024
Statut: ppublish

Résumé

The ability of a 1-time measurement of non-high-density lipoprotein cholesterol (non-HDL-C) or low-density lipoprotein cholesterol (LDL-C) to predict the cumulative exposure to these lipids during early adulthood (age 18-40 years) and the associated atherosclerotic cardiovascular disease (ASCVD) risk after age 40 years is not clear. The objectives of this study were to evaluate whether a 1-time measurement of non-HDL-C or LDL-C in a young adult can predict cumulative exposure to these lipids during early adulthood, and to quantify the association between cumulative exposure to non-HDL-C or LDL-C during early adulthood and the risk of ASCVD after age 40 years. We included CARDIA (Coronary Artery Risk Development in Young Adults Study) participants who were free of cardiovascular disease before age 40 years, were not taking lipid-lowering medications, and had ≥3 measurements of LDL-C and non-HDL-C before age 40 years. First, we assessed the ability of a 1-time measurement of LDL-C or non-HDL-C obtained between age 18 and 30 years to predict the quartile of cumulative lipid exposure from ages 18 to 40 years. Second, we assessed the associations between quartiles of cumulative lipid exposure from ages 18 to 40 years with ASCVD events (fatal and nonfatal myocardial infarction and stroke) after age 40 years. Of 4,104 CARDIA participants who had multiple lipid measurements before and after age 30 years, 3,995 participants met our inclusion criteria and were in the final analysis set. A 1-time measure of non-HDL-C and LDL-C had excellent discrimination for predicting membership in the top or bottom quartiles of cumulative exposure (AUC: 0.93 for the 4 models). The absolute values of non-HDL-C and LDL-C that predicted membership in the top quartiles with the highest simultaneous sensitivity and specificity (highest Youden's Index) were >135 mg/dL for non-HDL-C and >118 mg/dL for LDL-C; the values that predicted membership in the bottom quartiles were <107 mg/dL for non-HDL-C and <96 mg/dL for LDL-C. Individuals in the top quartile of non-HDL-C and LDL-C exposure had demographic-adjusted HRs of 4.6 (95% CI: 2.84-7.29) and 4.0 (95% CI: 2.50-6.33) for ASCVD events after age 40 years, respectively, when compared with each bottom quartile. Single measures of non-HDL-C and LDL-C obtained between ages 18 and 30 years are highly predictive of cumulative exposure before age 40 years, which in turn strongly predicts later-life ASCVD events.

Sections du résumé

BACKGROUND BACKGROUND
The ability of a 1-time measurement of non-high-density lipoprotein cholesterol (non-HDL-C) or low-density lipoprotein cholesterol (LDL-C) to predict the cumulative exposure to these lipids during early adulthood (age 18-40 years) and the associated atherosclerotic cardiovascular disease (ASCVD) risk after age 40 years is not clear.
OBJECTIVES OBJECTIVE
The objectives of this study were to evaluate whether a 1-time measurement of non-HDL-C or LDL-C in a young adult can predict cumulative exposure to these lipids during early adulthood, and to quantify the association between cumulative exposure to non-HDL-C or LDL-C during early adulthood and the risk of ASCVD after age 40 years.
METHODS METHODS
We included CARDIA (Coronary Artery Risk Development in Young Adults Study) participants who were free of cardiovascular disease before age 40 years, were not taking lipid-lowering medications, and had ≥3 measurements of LDL-C and non-HDL-C before age 40 years. First, we assessed the ability of a 1-time measurement of LDL-C or non-HDL-C obtained between age 18 and 30 years to predict the quartile of cumulative lipid exposure from ages 18 to 40 years. Second, we assessed the associations between quartiles of cumulative lipid exposure from ages 18 to 40 years with ASCVD events (fatal and nonfatal myocardial infarction and stroke) after age 40 years.
RESULTS RESULTS
Of 4,104 CARDIA participants who had multiple lipid measurements before and after age 30 years, 3,995 participants met our inclusion criteria and were in the final analysis set. A 1-time measure of non-HDL-C and LDL-C had excellent discrimination for predicting membership in the top or bottom quartiles of cumulative exposure (AUC: 0.93 for the 4 models). The absolute values of non-HDL-C and LDL-C that predicted membership in the top quartiles with the highest simultaneous sensitivity and specificity (highest Youden's Index) were >135 mg/dL for non-HDL-C and >118 mg/dL for LDL-C; the values that predicted membership in the bottom quartiles were <107 mg/dL for non-HDL-C and <96 mg/dL for LDL-C. Individuals in the top quartile of non-HDL-C and LDL-C exposure had demographic-adjusted HRs of 4.6 (95% CI: 2.84-7.29) and 4.0 (95% CI: 2.50-6.33) for ASCVD events after age 40 years, respectively, when compared with each bottom quartile.
CONCLUSIONS CONCLUSIONS
Single measures of non-HDL-C and LDL-C obtained between ages 18 and 30 years are highly predictive of cumulative exposure before age 40 years, which in turn strongly predicts later-life ASCVD events.

Identifiants

pubmed: 39232632
pii: S0735-1097(24)07818-5
doi: 10.1016/j.jacc.2024.05.070
pii:
doi:

Substances chimiques

Cholesterol, LDL 0
Cholesterol, HDL 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

961-973

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures This work was supported by National Heart, Lung, and Blood Institute R01HL146844. Dr Wilkins has served as a consultant for 3M (nonmedical division) that is not relevant to the content of this manuscript. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

John T Wilkins (JT)

Department of Medicine (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Preventive Medicine (Epidemiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Electronic address: j-wilkins@northwestern.edu.

Hongyan Ning (H)

Department of Preventive Medicine (Epidemiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Norrina B Allen (NB)

Department of Preventive Medicine (Epidemiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Alexander Zheutlin (A)

Department of Medicine (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Nilay S Shah (NS)

Department of Medicine (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Preventive Medicine (Epidemiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Matthew J Feinstein (MJ)

Department of Medicine (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Preventive Medicine (Epidemiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Amanda M Perak (AM)

Department of Medicine (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Pediatrics (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Sadiya S Khan (SS)

Department of Medicine (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Preventive Medicine (Epidemiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Ankeet S Bhatt (AS)

Kaiser Permanente, Division of Research, Oakland, California, USA.

Ravi Shah (R)

Department of Medicine (Cardiology), Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Venkatesh Murthy (V)

Department of Medicine (Cardiology), University of Michigan Medical School, Ann Arbor, Michigan, USA.

Allan Sniderman (A)

Department of Medicine (Cardiology), McGill University School of Medicine, Montreal, Quebec, Canada.

Donald M Lloyd-Jones (DM)

Department of Medicine (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Preventive Medicine (Epidemiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Pediatrics (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH